Open Peer Review Reports for: Gemcitabine in combination with EGF-Receptor antibody (Cetuximab) as a treatment of cholangiocarcinoma: a case report
Pre-publication versions of this article are available by contacting info@biomedcentral.com.
| Original Submission | ||
|---|---|---|
| 30 Jan 2006 | Submitted | Original manuscript |
| 26 Feb 2006 | Reviewed | Reviewer Report - Florian Eckel |
| 1 Mar 2006 | Reviewed | Reviewer Report - Vittorio Gebbia |
| 8 Mar 2006 | Reviewed | Reviewer Report - Tushar Patel |
| 5 Apr 2006 | Author responded | Author comments - Martin Franz Sprinzl |
| Resubmission - Version 2 | ||
| 5 Apr 2006 | Submitted | Manuscript version 2 |
| 3 May 2006 | Author responded | Author comments - Martin Franz Sprinzl |
| Resubmission - Version 3 | ||
| 3 May 2006 | Submitted | Manuscript version 3 |
| 3 May 2006 | Author responded | Author comments - Martin Franz Sprinzl |
| Resubmission - Version 4 | ||
| 3 May 2006 | Submitted | Manuscript version 4 |
| 12 Jun 2006 | Reviewed | Reviewer Report - Tushar Patel |
| 15 Jun 2006 | Author responded | Author comments - Martin Franz Sprinzl |
| Resubmission - Version 5 | ||
| 15 Jun 2006 | Submitted | Manuscript version 5 |
| 16 Jul 2006 | Author responded | Author comments - Martin Franz Sprinzl |
| Resubmission - Version 6 | ||
| 16 Jul 2006 | Submitted | Manuscript version 6 |
| Publishing | ||
| 17 Jul 2006 | Editorially accepted | |
| 17 Jul 2006 | Article published | 10.1186/1471-2407-6-190 |
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.
You can find further information about the peer review system here.
